<DOC>
	<DOC>NCT01768403</DOC>
	<brief_summary>Centralized Pan-Algerian Survey on the undertreatment of hypercholesterolemia. The purpose of this study is to establish the proportion of patients on lipid-lowering pharmacological treatment reaching the LDL-C goals according to the Third Joint European Task Force guidelines in the survey population.</brief_summary>
	<brief_title>Centralised Pan-Algerian Survey on the Undertreatment of Hypercholesterolemia</brief_title>
	<detailed_description>Centralised Pan-Algerian Survey on the undertreatment of hypercholesterolemia.</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<criteria>Subject must provide informed consent and comply with the survey procedures. Subject is on lipid lowering drug treatment for at least 3 months, with no dose change for a minimum of 6 weeks. Subjects who are unwilling or unable to provide informed consent.</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Hypercholesterolemia</keyword>
	<keyword>Cardiovascular disease</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Coronary Heart disease</keyword>
	<keyword>Peripheral Arterial disease</keyword>
</DOC>